You're currently on:

Antimicrobial Drug Discovery

Antimicrobial Drug Discovery

Edited by G Tegos, E Mylonakis

Availability: In stock

Antimicrobial Drug Discovery

Drug resistance is increasing among a variety of human pathogenic microorganisms such as Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumaniii, Pseudomonas aeruginosa and Enterobacter spp. (currently dubbed the 'ESKAPE' pathogens), and has emerged as one of the most important clinical challenges of this century. Increased general awareness and fear of these pathogens means there is a growing demand for research to tackle the threat of multidrug resistance. Documenting the latest research in the field, this book discusses current and promising activities to discover new antimicrobials in five key areas: molecular genetics and systems microbiology; synthetic, computational chemistry and chemoinformatics; High Throughput Screening (HTS); non-vertebrate model hosts; and light- and nano-based technologies.


Researchers and students in microbiology, biotechnology, pharmacology, chemistry and biology as well as medical professionals

Additional Information

Author Edited by G Tegos, E Mylonakis
Availability In Print
Dimensions Unknown
Extent 376 Pages
ISBN 9781845939434
Publication date Aug-12
Book Type Hardcover


1. Emerging Antimicrobial Drug-discovery Strategies: an Evolving Necessity

2. The Antibiotic Crisis

3. Structure, Genetic Regulation, Physiology and Function of the AcrAB-TolC Efflux Pump of Escherichia coli and Salmonella

4. Small-molecule Efflux Pump Inhibitors from Natural Products as a Potential Source of Antimicrobial Agents

5. Fungal Efflux-mediated Resistance: from Targets to Inhibitors

6. Vacuolar ATPase: a Model Proton Pump for Antifungal Drug Discovery

7. Drug Tolerance, Persister Cells and Drug Discovery

8. Inhibition of Quorum Sensing as a Novel Antimicrobial Strategy

9. Filamentous Temperature-sensitive Mutant Z (FtsZ) Protein as an Antibacterial Target

10. Lysostaphin: a Silver Bullet for Staph

11. Strategies to Identify Modified Ribosomally Synthesized Antimicrobials

12. Quantitative Structure-Activity Relationship-based Discovery of Antimicrobial Peptides Active Against Multidrug-resistant Bacteria

13. Acetyl-CoA Carboxylase as a Target for Antibacterial Development

14. Underexploited Targets in Lipopolysaccharide Biogenesis for the Design of Antibacterials

15. Predicting and Dissecting High-order Molecular Complexity by Information-driven Biomolecular Docking

16. Antifungals and Antifungal Drug Discovery

17. Pathosystematic Studies and the Rational Design of Antifungal Interventions

18. In Vivo High-throughput Antimicrobial Discovery Screens Utilizing Caenorhabditis elegans as an Alternative Host

19. Drosophila melanogaster as a Versatile Model for the Discovery of Drugs Effective against Human Microbe-induced Infection and Pathology

20. Antimicrobial Photosensitizers: Harnessing the Power of Light to Treat Infections

21. Nanoparticle Platforms for Antimicrobial Therapy

22. Antimicrobial Activity of Carbon Nanotubes

Delivery Information

DELIVERY DETAILS AND FEES Delivery method and cost is dependent on the destination country, product size and weight. Delivery time is 2-5 days for smaller items and up to 4 weeks for log stores and animal housing. Add your products to the cart and enter your destination country / county to get a delivery quote.

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.

Special books



Address: 5m Enterprises Ltd. Benchmark House, 8 Smithy Wood Drive, Sheffield, S35 1QN, England.

Mail to:

Phone: +44 (0)114 2464799

Fax: +44 (0)114 303 0085